INOVIO PHARMACEUTICALS, INC.

Develops DNA medicines delivered via smart devices for cancer, HPV, and infectious diseases.

INO | NDAQ

Overview

Corporate Details

ISIN(s):: US45773H4092
LEI:
Country:: United States of America
Address:: 660 W. GERMANTOWN PIKE, 19462 PLYMOUTH MEETING
Website:: https://www.inovio.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

INOVIO PHARMACEUTICALS, INC. is a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of DNA medicines. The company's proprietary platform designs DNA plasmids—small, circular DNA molecules that instruct the body's cells to produce specific proteins to target and fight disease. These DNA medicines are delivered directly into cells using INOVIO's proprietary investigational CELLECTRA® smart devices. This delivery method is designed for optimal effect without the use of chemical adjuvants, lipid nanoparticles, or viral vectors. INOVIO's development pipeline is focused on treatments and preventives for HPV-related diseases, cancer, and infectious diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all INOVIO PHARMACEUTICALS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for INOVIO PHARMACEUTICALS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for INOVIO PHARMACEUTICALS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
BridgeBio Pharma, Inc. Develops transformative medicines for genetic diseases and genetically driven cancers.	United States of America	BBIO
BRIGHT MINDS BIOSCIENCES INC. Developing next-gen serotonergic drugs for neurological and psychiatric disorders like epilepsy.	United States of America	DRUG
BRISTOL MYERS SQUIBB CO Develops innovative medicines for oncology, immunology, and cardiovascular diseases.	United States of America	BMY
BUKWANG PHARMACEUTICAL IND CO.,LTD R&D pharma firm developing drugs for CNS disorders, oncology, and metabolic diseases.	South Korea	003000
Burning Rock Biotech Ltd Offers NGS-based diagnostics for precision oncology, from detection to clinical trial support.	United States of America	BNR
C4 Therapeutics, Inc. Developing protein degrader medicines to treat cancer and other serious diseases.	United States of America	CCCC
Cabaletta Bio, Inc. Develops engineered T cell therapies for a curative reset in autoimmune diseases.	United States of America	CABA
Cadrenal Therapeutics, Inc. Developing novel anticoagulant therapies for high-risk cardiovascular patients.	United States of America	CVKD
CalciMedica, Inc. Develops CRAC channel inhibitors for critical illnesses like acute pancreatitis & AKI.	United States of America	CALC
Calidi Biotherapeutics, Inc. Develops immunotherapies using stem cells to deliver oncolytic viruses against solid tumors.	United States of America	CLDI